Free Trial

Doximity (DOCS) Financials

Doximity logo
$51.95 +0.31 (+0.59%)
Closing price 03:59 PM Eastern
Extended Trading
$51.96 +0.01 (+0.03%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Doximity

Annual Income Statements for Doximity

This table shows Doximity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Net Income / (Loss) Attributable to Common Shareholders
148 113 133 22 11
Consolidated Net Income / (Loss)
148 113 155 50 30
Net Income / (Loss) Continuing Operations
148 113 155 50 30
Total Pre-Tax Income
185 133 114 58 24
Total Operating Income
164 125 114 53 22
Total Gross Profit
425 366 304 176 101
Total Revenue
475 419 344 207 116
Operating Revenue
475 419 344 207 116
Total Cost of Revenue
51 53 40 31 15
Operating Cost of Revenue
51 53 40 31 15
Total Operating Expenses
261 240 190 122 79
Selling, General & Admin Expense
38 37 36 16 7.44
Marketing Expense
133 124 92 62 39
Research & Development Expense
82 80 62 44 32
Restructuring Charge
7.94 0.00 0.00 - -
Total Other Income / (Expense), net
21 8.05 0.47 4.47 1.35
Other Income / (Expense), net
21 8.05 0.47 4.47 1.35
Income Tax Expense
38 20 -41 7.56 -6.22
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.00 22 29 19
Basic Earnings per Share
$0.78 $0.58 $0.82 $0.29 $0.16
Weighted Average Basic Shares Outstanding
190.17M 193.18M 163.48M 74.34M 66.76M
Diluted Earnings per Share
$0.72 $0.53 $0.70 $0.23 $0.13
Weighted Average Diluted Shares Outstanding
205.73M 213.43M 191.02M 95.13M 81.71M
Weighted Average Basic & Diluted Shares Outstanding
185.43M 194.67M 193.11M - -

Quarterly Income Statements for Doximity

This table shows Doximity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Net Income / (Loss) Attributable to Common Shareholders
75 44 41 41 48 31 28 31 33 26 22
Consolidated Net Income / (Loss)
75 44 41 41 48 31 28 31 33 26 22
Net Income / (Loss) Continuing Operations
75 44 41 41 48 31 28 31 33 26 22
Total Pre-Tax Income
90 62 53 48 63 40 35 37 41 33 22
Total Operating Income
80 53 46 42 59 34 30 33 38 32 22
Total Gross Profit
154 123 113 105 123 101 95 97 102 89 78
Total Revenue
169 137 127 118 135 114 108 111 115 102 91
Operating Revenue
169 137 127 118 135 114 108 111 115 102 91
Total Cost of Revenue
14 14 14 13 12 13 13 14 14 13 13
Operating Cost of Revenue
14 14 14 13 12 13 13 14 14 13 13
Total Operating Expenses
74 70 67 64 65 67 66 64 63 57 56
Selling, General & Admin Expense
14 10 9.26 9.97 9.64 8.97 9.25 9.76 9.51 8.75 8.72
Marketing Expense
38 34 35 34 35 30 34 33 33 29 28
Research & Development Expense
22 23 23 20 20 20 22 22 21 19 19
Restructuring Charge
0.00 2.30 - - 0.00 7.94 - - 0.00 0.00 -
Total Other Income / (Expense), net
9.92 9.03 7.12 6.10 4.48 5.90 4.84 3.88 2.46 0.91 0.80
Income Tax Expense
15 18 12 7.34 15 9.09 6.12 6.05 7.48 6.71 0.10
Basic Earnings per Share
$0.40 $0.24 $0.22 $0.21 $0.26 $0.16 $0.15 $0.15 $0.17 $0.14 $0.12
Weighted Average Basic Shares Outstanding
187.16M 186.25M 185.61M 190.17M 186.31M 193.11M 194.52M 193.18M 192.81M 193.14M 192.95M
Diluted Earnings per Share
$0.37 $0.22 $0.21 $0.20 $0.24 $0.15 $0.13 $0.15 $0.16 $0.12 $0.10
Weighted Average Diluted Shares Outstanding
202.23M 200.41M 199.22M 205.73M 200.46M 209.01M 212.36M 213.43M 212.07M 213.95M 214.95M
Weighted Average Basic & Diluted Shares Outstanding
187.64M 186.69M 185.66M 185.43M 186.55M 185.91M 194.71M 194.67M 193.59M 192.49M 193.46M

Annual Cash Flow Statements for Doximity

This table details how cash moves in and out of Doximity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Net Change in Cash & Equivalents
-61 45 46 18 15
Net Cash From Operating Activities
184 180 127 83 26
Net Cash From Continuing Operating Activities
184 180 127 83 26
Net Income / (Loss) Continuing Operations
148 113 155 50 30
Consolidated Net Income / (Loss)
148 113 155 50 30
Depreciation Expense
10 10 5.04 3.70 0.90
Amortization Expense
3.63 12 14 7.08 4.63
Non-Cash Adjustments To Reconcile Net Income
55 52 34 5.39 4.30
Changes in Operating Assets and Liabilities, net
-32 -7.08 -82 17 -13
Net Cash From Investing Activities
31 -60 -641 -70 -13
Net Cash From Continuing Investing Activities
31 -60 -641 -70 -13
Purchase of Property, Plant & Equipment
-5.80 -6.18 -5.70 -4.61 -4.24
Acquisitions
0.00 -54 0.00 -32 0.00
Purchase of Investments
-473 -191 -1,317 -79 -79
Sale and/or Maturity of Investments
510 190 682 41 70
Other Investing Activities, net
0.00 0.00 0.60 -0.01 0.00
Net Cash From Financing Activities
-277 -74 560 5.41 1.72
Net Cash From Continuing Financing Activities
-277 -74 560 5.41 1.72
Repurchase of Common Equity
-281 -85 -6.68 -3.49 0.00
Issuance of Common Equity
16 15 568 8.90 0.00
Other Financing Activities, net
-12 -3.82 -0.82 0.00 1.72
Cash Income Taxes Paid
51 5.23 0.21 5.97 1.24

Quarterly Cash Flow Statements for Doximity

This table details how cash moves in and out of Doximity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Net Change in Cash & Equivalents
-19 73 15 -26 15 -198 149 22 63 -36 -2.72
Net Cash From Operating Activities
65 68 41 64 50 13 57 47 49 40 45
Net Cash From Continuing Operating Activities
65 68 41 65 50 13 57 47 49 40 45
Net Income / (Loss) Continuing Operations
75 44 41 41 48 31 28 31 33 26 22
Consolidated Net Income / (Loss)
75 44 41 41 48 31 28 31 33 26 22
Depreciation Expense
2.66 2.61 2.56 2.55 2.51 2.60 2.60 2.71 2.62 2.59 2.37
Amortization Expense
-1.58 -0.98 0.37 0.83 -0.14 0.57 2.37 2.40 1.99 3.29 4.22
Non-Cash Adjustments To Reconcile Net Income
20 21 17 13 13 14 14 14 16 12 9.91
Changes in Operating Assets and Liabilities, net
-31 1.30 -20 7.61 -13 -35 9.43 -2.92 -5.17 -4.86 5.86
Net Cash From Investing Activities
-59 24 30 -76 40 -50 117 -13 13 -19 -42
Net Cash From Continuing Investing Activities
-59 24 30 -76 40 -50 117 -13 13 -19 -42
Purchase of Property, Plant & Equipment
-1.77 -1.54 -1.70 -1.63 -1.32 -1.28 -1.56 -1.03 -1.22 -1.82 -2.13
Purchase of Investments
-164 -197 -170 -192 -101 -145 -35 -60 -39 -82 -8.87
Sale and/or Maturity of Investments
107 223 202 117 143 96 154 48 54 66 23
Net Cash From Financing Activities
-25 -20 -57 -14 -76 -161 -26 -12 0.78 -57 -5.97
Net Cash From Continuing Financing Activities
-25 -20 -57 -14 -76 -161 -26 -12 0.78 -57 -5.97
Repurchase of Common Equity
-19 -23 -51 -18 -77 -164 -22 -15 - -61 -8.87
Issuance of Common Equity
3.66 9.11 2.55 5.09 2.54 5.43 3.29 4.89 1.87 4.91 3.01
Other Financing Activities, net
-9.60 -5.83 -7.86 -1.42 -1.25 -2.12 -7.35 -1.47 -1.09 -1.15 -0.11
Cash Income Taxes Paid
14 9.08 13 13 8.93 29 0.00 2.73 2.38 0.12 0.00

Annual Balance Sheets for Doximity

This table presents Doximity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021
Total Assets
1,079 1,137 991 252
Total Current Assets
913 975 904 209
Cash & Equivalents
97 158 113 66
Short-Term Investments
666 683 685 76
Accounts Receivable
101 107 81 50
Prepaid Expenses
49 27 19 11
Plant, Property, & Equipment, net
12 11 8.49 7.60
Total Noncurrent Assets
154 150 79 35
Goodwill
68 68 19 19
Intangible Assets
27 32 7.91 9.60
Noncurrent Deferred & Refundable Income Taxes
45 35 49 2.11
Other Noncurrent Operating Assets
14 15 3.35 4.10
Total Liabilities & Shareholders' Equity
1,079 1,137 991 252
Total Liabilities
178 171 113 104
Total Current Liabilities
147 140 111 102
Accounts Payable
2.25 1.27 0.46 1.52
Accrued Expenses
44 31 25 16
Current Deferred Revenue
99 105 85 83
Other Current Liabilities
2.15 1.75 0.64 0.97
Total Noncurrent Liabilities
31 31 1.48 1.48
Noncurrent Deferred Revenue
0.21 0.20 0.08 0.22
Other Noncurrent Operating Liabilities
31 31 1.40 1.26
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
901 966 879 67
Total Preferred & Common Equity
901 966 879 67
Preferred Stock
0.00 0.00 0.00 0.00
Total Common Equity
901 966 879 67
Common Stock
824 762 703 30
Retained Earnings
80 218 191 36
Accumulated Other Comprehensive Income / (Loss)
-2.66 -14 -15 -0.02

Quarterly Balance Sheets for Doximity

This table presents Doximity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021
Total Assets
1,172 1,119 1,073 1,001 1,026 1,154 1,067 1,028 1,051 932
Total Current Assets
1,013 958 908 841 863 990 899 848 874 858
Cash & Equivalents
165 184 111 123 108 307 136 74 110 85
Short-Term Investments
680 621 639 587 621 566 665 676 666 680
Accounts Receivable
138 125 121 98 97 93 75 79 76 70
Prepaid Expenses
30 27 37 27 33 20 17 16 18 18
Plant, Property, & Equipment, net
13 13 13 12 12 12 12 12 11 8.22
Total Noncurrent Assets
146 148 152 148 151 152 157 169 165 66
Goodwill
68 68 68 68 68 68 68 68 68 19
Intangible Assets
24 25 26 28 29 31 33 34 35 8.80
Noncurrent Deferred & Refundable Income Taxes
43 44 45 37 39 39 40 51 49 35
Other Noncurrent Operating Assets
11 11 13 14 14 15 16 16 13 2.43
Total Liabilities & Shareholders' Equity
1,172 1,119 1,073 1,001 1,026 1,154 1,067 1,028 1,051 932
Total Liabilities
141 157 160 136 154 163 137 149 149 93
Total Current Liabilities
116 132 135 105 123 133 106 118 121 92
Accounts Payable
1.64 2.77 1.66 1.88 0.71 0.58 1.60 1.11 0.92 1.23
Accrued Expenses
43 34 28 34 29 32 33 26 25 24
Current Deferred Revenue
69 94 103 67 91 98 70 90 94 66
Other Current Liabilities
2.26 2.22 2.19 2.11 1.94 2.05 1.46 1.01 0.68 0.93
Total Noncurrent Liabilities
25 25 25 31 31 30 31 31 28 1.61
Noncurrent Deferred Revenue
0.07 0.15 0.12 0.17 0.24 0.19 0.14 0.17 0.20 0.04
Other Noncurrent Operating Liabilities
25 25 24 25 31 30 31 31 28 1.57
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,031 961 914 865 871 991 930 879 902 839
Total Preferred & Common Equity
1,031 961 914 865 871 991 930 879 902 839
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,031 961 914 865 871 991 930 879 902 839
Common Stock
879 863 842 808 795 778 746 731 715 688
Retained Earnings
151 95 73 61 85 225 203 170 205 154
Accumulated Other Comprehensive Income / (Loss)
1.02 2.68 -1.01 -4.65 -8.93 -12 -19 -22 -18 -4.01

Annual Metrics And Ratios for Doximity

This table displays calculated financial ratios and metrics derived from Doximity's official financial filings.

Metric 2024 2023 2022 2021 2020
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Growth Metrics
- - - - -
Revenue Growth
13.45% 21.98% 66.05% 77.76% 0.00%
EBITDA Growth
28.17% 16.68% 94.21% 136.03% 0.00%
EBIT Growth
39.09% 16.80% 97.35% 145.68% 0.00%
NOPAT Growth
23.20% -31.23% 232.73% 65.29% 0.00%
Net Income Growth
30.81% -27.11% 208.27% 68.85% 0.00%
EPS Growth
35.85% -24.29% 204.35% 76.92% 0.00%
Operating Cash Flow Growth
2.50% 41.89% 52.55% 216.70% 0.00%
Free Cash Flow Firm Growth
91.01% -22.65% 95.10% 0.00% 0.00%
Invested Capital Growth
10.69% 55.46% 1,320.17% 0.00% 0.00%
Revenue Q/Q Growth
1.51% 4.31% 8.52% 0.00% 0.00%
EBITDA Q/Q Growth
16.78% 9.02% 5.32% 0.00% 0.00%
EBIT Q/Q Growth
19.59% 10.79% 4.41% 0.00% 0.00%
NOPAT Q/Q Growth
6.58% -7.75% 11.00% 0.00% 0.00%
Net Income Q/Q Growth
7.23% -5.10% 10.92% 0.00% 0.00%
EPS Q/Q Growth
7.46% -5.36% 2.94% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
10.38% -0.18% 8.03% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
20.39% 4.07% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-10.29% -3.17% 9.84% 0.00% 0.00%
Profitability Metrics
- - - - -
Gross Margin
89.34% 87.24% 88.42% 84.92% 87.20%
EBITDA Margin
41.88% 37.07% 38.75% 33.13% 24.95%
Operating Margin
34.47% 29.86% 33.05% 25.76% 19.04%
EBIT Margin
38.96% 31.78% 33.18% 27.92% 20.20%
Profit (Net Income) Margin
31.04% 26.92% 45.05% 24.27% 25.55%
Tax Burden Percent
79.69% 84.73% 135.77% 86.92% 126.47%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
20.31% 15.27% -35.77% 13.08% -26.47%
Return on Invested Capital (ROIC)
99.08% 103.11% 357.86% 1,635.02% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
96.96% 102.28% 357.73% 1,629.58% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-83.27% -90.88% -327.72% -1,567.26% 0.00%
Return on Equity (ROE)
15.81% 12.23% 30.15% 67.76% 0.00%
Cash Return on Invested Capital (CROIC)
88.93% 59.69% 184.18% 1,435.02% 0.00%
Operating Return on Assets (OROA)
16.71% 12.51% 18.34% 22.95% 0.00%
Return on Assets (ROA)
13.32% 10.60% 24.90% 19.95% 0.00%
Return on Common Equity (ROCE)
15.81% 12.23% 27.76% 30.52% 0.00%
Return on Equity Simple (ROE_SIMPLE)
16.37% 11.68% 17.62% 75.23% 0.00%
Net Operating Profit after Tax (NOPAT)
131 106 154 46 28
NOPAT Margin
27.47% 25.30% 44.87% 22.39% 24.08%
Net Nonoperating Expense Percent (NNEP)
2.12% 0.83% 0.14% 5.45% 0.00%
Cost of Revenue to Revenue
10.66% 12.76% 11.58% 15.08% 12.80%
SG&A Expenses to Revenue
7.96% 8.77% 10.41% 7.97% 6.39%
R&D to Revenue
17.24% 19.14% 18.15% 21.21% 27.87%
Operating Expenses to Revenue
54.87% 57.38% 55.37% 59.16% 68.16%
Earnings before Interest and Taxes (EBIT)
185 133 114 58 24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
199 155 133 69 29
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
5.57 6.49 11.34 9.08 0.00
Price to Tangible Book Value (P/TBV)
6.23 7.24 11.70 15.85 0.00
Price to Revenue (P/Rev)
10.56 14.96 29.01 2.93 5.21
Price to Earnings (P/E)
34.02 55.56 74.78 28.10 55.94
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.94% 1.80% 1.34% 3.56% 1.79%
Enterprise Value to Invested Capital (EV/IC)
30.74 43.38 113.91 96.12 0.00
Enterprise Value to Revenue (EV/Rev)
8.95 12.95 26.68 2.63 0.00
Enterprise Value to EBITDA (EV/EBITDA)
21.38 34.94 68.86 7.95 0.00
Enterprise Value to EBIT (EV/EBIT)
22.99 40.76 80.41 9.43 0.00
Enterprise Value to NOPAT (EV/NOPAT)
32.60 51.20 59.47 11.76 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
23.13 30.22 72.43 6.57 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
36.32 88.45 115.56 13.40 0.00
Leverage & Solvency
- - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.86 -0.89 -0.92 -0.96 0.00
Leverage Ratio
1.19 1.15 1.21 1.70 0.00
Compound Leverage Factor
1.19 1.15 1.21 1.70 0.00
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 54.96% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 45.04% 0.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Altman Z-Score
18.89 23.93 54.98 5.80 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 7.93% 54.96% 0.00%
Liquidity Ratios
- - - - -
Current Ratio
6.20 6.99 8.12 2.05 0.00
Quick Ratio
5.87 6.80 7.90 1.89 0.00
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
117 61 79 41 0.00
Operating Cash Flow to CapEx
3,173.52% 2,904.30% 2,221.78% 1,799.85% 617.32%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - -
Asset Turnover
0.43 0.39 0.55 0.82 0.00
Accounts Receivable Turnover
4.56 4.46 5.23 4.11 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
40.30 42.40 42.71 27.23 0.00
Accounts Payable Turnover
28.75 61.66 40.23 20.59 0.00
Days Sales Outstanding (DSO)
79.99 81.93 69.80 88.77 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
12.70 5.92 9.07 17.73 0.00
Cash Conversion Cycle (CCC)
67.29 76.01 60.73 71.05 0.00
Capital & Investment Metrics
- - - - -
Invested Capital
138 125 80 5.67 0.00
Invested Capital Turnover
3.61 4.08 7.98 73.02 0.00
Increase / (Decrease) in Invested Capital
13 45 75 5.67 0.00
Enterprise Value (EV)
4,257 5,427 9,167 545 0.00
Market Capitalization
5,020 6,268 9,966 606 606
Book Value per Share
$4.83 $4.99 $4.59 $0.90 $0.00
Tangible Book Value per Share
$4.32 $4.48 $4.45 $0.51 $0.00
Total Capital
901 966 879 148 0.00
Total Debt
0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00
Net Debt
-763 -841 -798 -143 0.00
Capital Expenditures (CapEx)
5.80 6.18 5.70 4.61 4.24
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2.79 -5.05 -5.26 -35 0.00
Debt-free Net Working Capital (DFNWC)
766 836 793 107 0.00
Net Working Capital (NWC)
766 836 793 107 0.00
Net Nonoperating Expense (NNE)
-17 -6.82 -0.64 -3.88 -1.71
Net Nonoperating Obligations (NNO)
-763 -841 -798 -143 0.00
Total Depreciation and Amortization (D&A)
14 22 19 11 5.53
Debt-free, Cash-free Net Working Capital to Revenue
0.59% -1.21% -1.53% -17.00% 0.00%
Debt-free Net Working Capital to Revenue
161.06% 199.49% 230.78% 51.89% 0.00%
Net Working Capital to Revenue
161.06% 199.49% 230.78% 51.89% 0.00%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.78 $0.58 $0.82 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
190.17M 193.18M 163.48M 0.00 0.00
Adjusted Diluted Earnings per Share
$0.72 $0.53 $0.70 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
205.73M 213.43M 191.02M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
185.43M 194.67M 193.11M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
137 106 79 46 16
Normalized NOPAT Margin
28.80% 25.30% 23.13% 22.39% 13.33%
Pre Tax Income Margin
38.96% 31.78% 33.18% 27.92% 20.20%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
190.21% 75.63% 4.32% 6.95% 0.00%

Quarterly Metrics And Ratios for Doximity

This table displays calculated financial ratios and metrics derived from Doximity's official financial filings.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
24.63% 20.44% 16.79% 6.39% 17.37% 11.18% 19.67% 18.49% 17.76% 28.78% 24.73%
EBITDA Growth
32.95% 48.20% 41.34% 19.19% 41.39% -2.68% 22.57% 14.54% 7.23% 25.57% -4.40%
EBIT Growth
36.50% 57.26% 55.15% 27.44% 52.14% 5.27% 36.90% 17.69% 7.47% 26.53% -12.99%
NOPAT Growth
50.17% 44.87% 46.74% 29.23% 41.61% 1.86% 13.17% -25.35% -43.44% -27.94% -17.86%
Net Income Growth
56.80% 44.28% 45.66% 32.44% 43.29% 16.36% 26.91% -16.50% -39.86% -27.13% -14.96%
EPS Growth
54.17% 46.67% 61.54% 33.33% 50.00% 25.00% 30.00% -16.67% -38.46% -29.41% 11.11%
Operating Cash Flow Growth
30.24% 429.90% -27.90% 37.10% 2.79% -67.36% 27.82% -0.69% 78.48% 106.32% 34.90%
Free Cash Flow Firm Growth
81.08% 76.84% -129.46% 228.28% 179.16% 118.25% 131.98% 54.80% -38.68% -1,414.45% -521.52%
Invested Capital Growth
20.60% 9.90% 38.67% 10.69% 19.48% 9.80% -6.59% 55.46% 76.35% 331.36% 6,201.90%
Revenue Q/Q Growth
23.22% 8.02% 7.30% -12.73% 19.08% 4.74% -2.25% -3.73% 12.80% 12.74% -3.22%
EBITDA Q/Q Growth
47.86% 11.84% 8.29% -25.76% 64.82% 6.66% -8.68% -11.93% 13.45% 34.33% -14.66%
EBIT Q/Q Growth
50.40% 15.39% 10.04% -28.52% 73.27% 13.84% -9.62% -14.66% 19.88% 48.05% -22.30%
NOPAT Q/Q Growth
77.25% 5.31% 1.10% -20.42% 71.00% 6.66% -10.96% -12.80% 22.99% 18.50% -41.27%
Net Income Q/Q Growth
70.30% 6.71% 1.87% -15.30% 56.71% 7.73% -7.38% -8.37% 27.26% 17.50% -39.05%
EPS Q/Q Growth
68.18% 4.76% 5.00% -16.67% 60.00% 15.38% -13.33% -6.25% 33.33% 20.00% -44.44%
Operating Cash Flow Q/Q Growth
-4.62% 65.72% -35.50% 27.75% 288.08% -77.45% 22.64% -4.23% 23.24% -11.70% -4.71%
Free Cash Flow Firm Q/Q Growth
47.97% 346.05% -143.67% 13.88% 44.50% -59.02% 290.19% 29.73% 66.69% 28.18% -168.82%
Invested Capital Q/Q Growth
19.62% -4.57% 17.76% -10.29% 9.01% 20.40% -6.00% -3.17% 0.18% 2.43% 56.45%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
91.59% 90.01% 89.30% 89.36% 90.99% 88.77% 87.87% 87.67% 88.27% 87.07% 85.57%
EBITDA Margin
48.04% 40.03% 38.67% 38.31% 45.03% 32.54% 31.95% 34.20% 37.38% 37.17% 31.19%
Operating Margin
47.40% 38.84% 36.36% 35.45% 43.28% 29.74% 27.37% 29.60% 33.39% 31.41% 23.92%
EBIT Margin
47.40% 38.84% 36.36% 35.45% 43.28% 29.74% 27.37% 29.60% 33.39% 31.41% 23.92%
Profit (Net Income) Margin
44.60% 32.27% 32.66% 34.41% 35.45% 26.94% 26.19% 27.64% 29.04% 25.74% 24.69%
Tax Burden Percent
83.70% 71.02% 77.82% 84.70% 76.08% 77.09% 82.28% 83.53% 81.74% 79.67% 99.54%
Interest Burden Percent
112.41% 116.99% 115.45% 114.58% 107.65% 117.47% 116.30% 111.80% 106.39% 102.83% 103.71%
Effective Tax Rate
16.30% 28.98% 22.18% 15.30% 23.92% 22.91% 17.72% 16.47% 18.26% 20.33% 0.46%
Return on Invested Capital (ROIC)
128.20% 95.92% 99.50% 108.31% 108.76% 75.98% 80.79% 100.77% 108.30% 121.10% 134.60%
ROIC Less NNEP Spread (ROIC-NNEP)
127.13% 95.08% 98.82% 107.67% 108.31% 75.37% 80.31% 100.38% 108.04% 121.01% 134.49%
Return on Net Nonoperating Assets (RNNOA)
-104.29% -79.66% -84.26% -92.47% -91.20% -63.72% -69.98% -89.19% -95.67% -109.36% -123.94%
Return on Equity (ROE)
23.91% 16.26% 15.25% 15.84% 17.56% 12.27% 10.81% 11.58% 12.62% 11.74% 10.66%
Cash Return on Invested Capital (CROIC)
84.54% 93.87% 68.75% 88.93% 68.66% 71.44% 96.29% 59.69% 58.24% 50.29% 39.51%
Operating Return on Assets (OROA)
24.01% 18.72% 16.12% 15.21% 19.61% 12.98% 10.85% 11.65% 13.42% 12.73% 9.19%
Return on Assets (ROA)
22.59% 15.56% 14.48% 14.76% 16.06% 11.76% 10.38% 10.88% 11.67% 10.43% 9.49%
Return on Common Equity (ROCE)
23.91% 16.26% 15.25% 15.84% 17.56% 12.27% 10.81% 11.58% 12.62% 11.74% 10.66%
Return on Equity Simple (ROE_SIMPLE)
19.53% 18.11% 17.57% 0.00% 15.92% 14.13% 11.99% 0.00% 12.78% 16.05% 16.72%
Net Operating Profit after Tax (NOPAT)
67 38 36 35 45 26 24 27 31 26 22
NOPAT Margin
39.68% 27.58% 28.29% 30.03% 32.93% 22.93% 22.52% 24.72% 27.29% 25.03% 23.81%
Net Nonoperating Expense Percent (NNEP)
1.07% 0.84% 0.68% 0.64% 0.45% 0.62% 0.48% 0.39% 0.26% 0.10% 0.11%
Return On Investment Capital (ROIC_SIMPLE)
6.49% - - - 5.15% - - - - - -
Cost of Revenue to Revenue
8.41% 9.99% 10.70% 10.64% 9.01% 11.23% 12.13% 12.33% 11.74% 12.93% 14.43%
SG&A Expenses to Revenue
8.06% 7.38% 7.31% 8.45% 7.13% 7.89% 8.53% 8.79% 8.25% 8.56% 9.63%
R&D to Revenue
13.30% 16.98% 17.82% 17.07% 14.74% 17.57% 20.22% 19.41% 17.80% 18.70% 20.99%
Operating Expenses to Revenue
44.18% 51.17% 52.95% 53.90% 47.71% 59.03% 60.51% 58.08% 54.88% 55.66% 61.65%
Earnings before Interest and Taxes (EBIT)
80 53 46 42 59 34 30 33 38 32 22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
81 55 49 45 61 37 35 38 43 38 28
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
9.67 8.42 5.68 5.57 6.03 4.74 6.68 6.49 6.94 6.65 7.45
Price to Tangible Book Value (P/TBV)
10.61 9.32 6.33 6.23 6.79 5.34 7.42 7.24 7.79 7.53 8.42
Price to Revenue (P/Rev)
18.12 15.65 10.51 10.56 11.13 9.22 15.16 14.96 16.08 15.21 18.60
Price to Earnings (P/E)
49.50 46.46 32.30 34.02 37.88 33.55 55.73 55.56 57.20 43.27 46.41
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.02% 2.15% 3.10% 2.94% 2.64% 2.98% 1.79% 1.80% 1.75% 2.31% 2.15%
Enterprise Value to Invested Capital (EV/IC)
49.00 46.80 27.20 30.74 29.17 24.02 48.88 43.38 43.80 39.52 47.24
Enterprise Value to Revenue (EV/Rev)
16.58 14.09 8.99 8.95 9.61 7.59 13.16 12.95 14.09 13.26 16.45
Enterprise Value to EBITDA (EV/EBITDA)
39.66 34.70 23.09 21.38 26.41 22.29 37.41 34.94 39.71 36.52 45.26
Enterprise Value to EBIT (EV/EBIT)
41.28 36.49 24.61 22.99 29.07 25.24 43.19 40.76 47.08 43.38 53.90
Enterprise Value to NOPAT (EV/NOPAT)
51.90 47.44 31.25 32.60 36.75 31.13 52.77 51.20 49.25 36.66 39.87
Enterprise Value to Operating Cash Flow (EV/OCF)
38.21 32.58 26.38 23.13 27.00 20.56 29.94 30.22 31.45 32.15 43.05
Enterprise Value to Free Cash Flow (EV/FCFF)
63.37 52.21 45.97 36.32 46.25 35.20 49.04 88.45 95.97 127.57 235.37
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.82 -0.84 -0.85 -0.86 -0.84 -0.85 -0.87 -0.89 -0.89 -0.90 -0.92
Leverage Ratio
1.15 1.17 1.17 1.19 1.15 1.17 1.16 1.15 1.13 1.15 1.15
Compound Leverage Factor
1.29 1.37 1.35 1.36 1.24 1.38 1.35 1.29 1.20 1.18 1.20
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
44.20 32.48 21.02 18.45 24.62 17.61 26.05 23.64 29.96 25.04 28.66
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
8.74 7.24 6.72 6.20 8.03 7.00 7.46 6.99 8.49 7.18 7.24
Quick Ratio
8.48 7.03 6.44 5.87 7.71 6.71 7.28 6.80 8.27 7.02 7.06
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
35 24 -9.64 22 19 13 33 -17 -24 -73 -102
Operating Cash Flow to CapEx
3,680.91% 4,429.42% 2,420.36% 3,913.34% 3,780.51% 1,008.44% 3,657.29% 4,545.71% 4,004.69% 2,174.68% 2,105.98%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.51 0.48 0.44 0.43 0.45 0.44 0.40 0.39 0.40 0.41 0.38
Accounts Receivable Turnover
4.68 4.66 4.62 4.56 5.43 5.08 5.17 4.46 5.55 5.70 5.93
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
43.46 42.02 40.28 40.30 40.10 38.27 37.96 42.40 40.70 39.12 37.98
Accounts Payable Turnover
30.70 29.84 45.64 28.75 29.72 58.37 71.52 61.66 36.40 52.08 24.82
Days Sales Outstanding (DSO)
77.98 78.39 79.06 79.99 67.20 71.83 70.57 81.93 65.73 64.06 61.59
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
11.89 12.23 8.00 12.70 12.28 6.25 5.10 5.92 10.03 7.01 14.70
Cash Conversion Cycle (CCC)
66.09 66.16 71.06 67.29 54.92 65.58 65.47 76.01 55.70 57.05 46.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
186 156 163 138 154 142 118 125 129 129 126
Invested Capital Turnover
3.23 3.48 3.52 3.61 3.30 3.31 3.59 4.08 3.97 4.84 5.65
Increase / (Decrease) in Invested Capital
32 14 45 13 25 13 -8.30 45 56 99 124
Enterprise Value (EV)
9,123 7,284 4,436 4,257 4,503 3,402 5,749 5,427 5,659 5,096 5,948
Market Capitalization
9,967 8,089 5,186 5,020 5,213 4,132 6,623 6,268 6,460 5,846 6,724
Book Value per Share
$5.52 $5.18 $4.93 $4.83 $4.65 $4.48 $5.09 $4.99 $4.83 $4.54 $4.67
Tangible Book Value per Share
$5.03 $4.68 $4.42 $4.32 $4.13 $3.98 $4.58 $4.48 $4.31 $4.02 $4.14
Total Capital
1,031 961 914 901 865 871 991 966 930 879 902
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-845 -806 -750 -763 -710 -730 -873 -841 -801 -750 -776
Capital Expenditures (CapEx)
1.77 1.54 1.70 1.63 1.32 1.28 1.56 1.03 1.22 1.82 2.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
52 20 23 2.79 26 9.79 -16 -5.05 -8.33 -20 -23
Debt-free Net Working Capital (DFNWC)
897 825 773 766 736 740 857 836 793 730 753
Net Working Capital (NWC)
897 825 773 766 736 740 857 836 793 730 753
Net Nonoperating Expense (NNE)
-8.30 -6.41 -5.54 -5.17 -3.41 -4.55 -3.98 -3.24 -2.01 -0.72 -0.80
Net Nonoperating Obligations (NNO)
-845 -806 -750 -763 -710 -730 -873 -841 -801 -750 -776
Total Depreciation and Amortization (D&A)
1.07 1.64 2.93 3.38 2.37 3.17 4.97 5.11 4.61 5.88 6.59
Debt-free, Cash-free Net Working Capital to Revenue
9.43% 3.84% 4.60% 0.59% 5.53% 2.18% -3.71% -1.21% -2.07% -5.26% -6.32%
Debt-free Net Working Capital to Revenue
163.01% 159.70% 156.63% 161.06% 157.18% 164.98% 196.15% 199.49% 197.30% 189.87% 208.40%
Net Working Capital to Revenue
163.01% 159.70% 156.63% 161.06% 157.18% 164.98% 196.15% 199.49% 197.30% 189.87% 208.40%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.40 $0.24 $0.22 $0.21 $0.26 $0.16 $0.15 $0.15 $0.17 $0.14 $0.12
Adjusted Weighted Average Basic Shares Outstanding
187.16M 186.25M 185.61M 190.17M 186.31M 193.11M 194.52M 193.18M 192.81M 193.14M 192.95M
Adjusted Diluted Earnings per Share
$0.37 $0.22 $0.21 $0.20 $0.24 $0.15 $0.13 $0.15 $0.16 $0.12 $0.10
Adjusted Weighted Average Diluted Shares Outstanding
202.23M 200.41M 199.22M 205.73M 200.46M 209.01M 212.36M 213.43M 212.07M 213.95M 214.95M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
187.64M 186.69M 185.66M 185.43M 186.55M 185.91M 194.71M 194.67M 193.59M 192.49M 193.46M
Normalized Net Operating Profit after Tax (NOPAT)
67 39 36 35 45 32 24 27 31 26 22
Normalized NOPAT Margin
39.68% 28.78% 28.29% 30.03% 32.93% 28.32% 22.52% 24.72% 27.29% 25.03% 23.81%
Pre Tax Income Margin
53.28% 45.44% 41.97% 40.62% 46.59% 34.94% 31.83% 33.09% 35.52% 32.30% 24.81%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
55.25% 96.91% 193.19% 190.21% 202.18% 163.60% 82.64% 75.63% 58.92% 49.66% 7.35%

Frequently Asked Questions About Doximity's Financials

When does Doximity's financial year end?

According to the most recent income statement we have on file, Doximity's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has Doximity's net income changed over the last 4 years?

Doximity's net income appears to be on an upward trend, with a most recent value of $147.58 million in 2024, rising from $29.74 million in 2020. The previous period was $112.82 million in 2023. Check out Doximity's forecast to explore projected trends and price targets.

What is Doximity's operating income?
Doximity's total operating income in 2024 was $163.88 million, based on the following breakdown:
  • Total Gross Profit: $424.75 million
  • Total Operating Expenses: $260.88 million
How has Doximity revenue changed over the last 4 years?

Over the last 4 years, Doximity's total revenue changed from $116.39 million in 2020 to $475.42 million in 2024, a change of 308.5%.

How much debt does Doximity have?

Doximity's total liabilities were at $177.98 million at the end of 2024, a 4.2% increase from 2023, and a 71.9% increase since 2021.

How much cash does Doximity have?

In the past 3 years, Doximity's cash and equivalents has ranged from $66.39 million in 2021 to $158.03 million in 2023, and is currently $96.79 million as of their latest financial filing in 2024.

How has Doximity's book value per share changed over the last 4 years?

Over the last 4 years, Doximity's book value per share changed from 0.00 in 2020 to 4.83 in 2024, a change of 483.2%.



This page (NASDAQ:DOCS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners